Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-blocker withdrawal in heart failure with right ventricular dysfunction
2011-000890-29Phase 4Completed
- Sponsor
- Fondazione Centro San Raffaele
- Start
- Mar 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bisoprolol, carvedilol, metoprolol and nebivolol in heart failure (HF) (2 arms), sponsored by Fondazione Centro San Raffaele. Primary endpoint: Exercise tolerance measured by VO2 at 6 months. Started Mar 2012; status: completed.
02
Drugs
bisoprololcarvedilolmetoprololnebivolol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2011-000890-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000890-29.